(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with niacin in 1 studies
Studies ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Trials ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Recent Studies (post-2010) ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Studies (niacin) | Trials (niacin) | Recent Studies (post-2010) (niacin) |
---|---|---|---|---|---|
85 | 0 | 65 | 11,974 | 462 | 1,488 |
Protein | Taxonomy | (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide (IC50) | niacin (IC50) |
---|---|---|---|
Cholesteryl ester transfer protein | Homo sapiens (human) | 0.14 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.14 | |
Hydroxycarboxylic acid receptor 2 | Homo sapiens (human) | 0.1726 | |
Hydroxycarboxylic acid receptor 2 | Mus musculus (house mouse) | 0.14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clifton, HL; Inceoglu, B; Ma, L; Schaefer, S; Zheng, J | 1 |
1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and niacin
Article | Year |
---|---|
TRPV1 channels are involved in niacin-induced cutaneous vasodilation in mice.
Topics: Acrylamides; Animals; Bridged Bicyclo Compounds, Heterocyclic; Capsaicin; Disease Models, Animal; Flushing; Mice; Mice, Knockout; Niacin; Sensory System Agents; TRPV Cation Channels; Vasodilation; Vasodilator Agents | 2015 |